Biomarker for bladder cancer
Miyazaki, J.; Nishiyama, H.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(1): 48-53
2012
ISSN/ISBN: 0385-0684 PMID: 22454984 Document Number: 656754
Document emailed within 1 workday
Related Documents
Zhang, Z.; Hao, H.; Zhang, C.-j.; Yang, X.-y.; He, Q.; Lin, J. 2012: Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer Zhonghua Yi Xue Za Zhi 92(6): 384-387Del Zingaro, M.; Bruno, R.; Nunzi, E.; Porena, M.; Mearini, L. 2016: First and second transurethral resections in intermediate-high risk bladder cancer: impact of the surgeon's volume on the recurrence and progression of primary bladder cancer Minerva Urologica e Nefrologica 68(2): 194-203
Nagasaka, T.; Mori, Y.; Umeda, Y.; Fujiwara, T. 2012: Biomarker for colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 70(5): 802-808
Presl, J.; Kučera, R.; Topolčan, O.; Novotný, Z.; Vrzalová, J.; Fuchsova, R.; Betincová, L.; Rokyta, Z. 2012: HE4 a biomarker of ovarian cancer Ceska Gynekologie 77(5): 445-449
Yucel, E.; Ilter, E.; Aksungar, F.B.; Celik, A.; Peker, B.H.; Serifsoy, E.; Bozkurt, S. 2017: HE4: really a novel biomarker for ovarian cancer? European Journal of Gynaecological Oncology 38(1): 59-64
Kondo, T. 2012: Biomarker development by cancer proteomics Nihon Rinsho. Japanese Journal of Clinical Medicine 70(5): 754-758
Mommsen, S.; Jakobsen, A.; Sell, A. 1989: Quality of life in patients with advanced bladder cancer. a randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201) Scandinavian Journal of Urology and Nephrology. Supplementum 125: 115-120
Aihara, R.; Sato, K.; Sasaki, K.; Hosaka, Y.; Narita, T. 1985: Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient in the terminal stage of bladder cancer with poor prognosis Nursing Technique 31(11): 1492-1497
Matsusaka, S. 2009: Biomarker for chemotherapy in patients with colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(1): 11-14
Hazama, S.; Maeda, K.; Oka, M. 2012: Epitope peptide vaccine with oncoantigen for cancer and its biomarker Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2189-2193
Ito, A.; Kawasaki, Y.; Kakoi, N.; Shimada, S.; Saito, S.; Arai, Y. 2016: Disialosyl globopentaosylceramide (DSGb5) as a biomarker of prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 196-200
Kawamoto, H.; Fukuda, M. 2007: Present conditions and the prospects for biomarker measurement in breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 6): 281-284
Terakawa, H.; Oyama, K.; Watanabe, T.; Tsukada, T.; Okamoto, K.; Kinoshita, J.; Furukawa, H.; Makino, I.; Nakamura, K.; Hayashi, H.; Inokuchi, M.; Nakagawara, H.; Miyashita, T.; Tajima, H.; Takamura, H.; Ninomiya, I.; Kitagawa, H.; Fushida, S.; Fujimura, T.; Ohta, T. 2014: A case of advanced gastric cancer in which the serum HER2-ECD level could be used as a biomarker Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(4): 491-493
Gilbert, F.; Walop, W.; Chan, J.S.; Benjannet, S.; Seidah, N.G.; Spitzer, W.O.; Chrétien, M. 1987: The role of the NH2-terminal portion of pro-opiomelanocortin as a biomarker for human lung cancer Clinical and Investigative Medicine. Medecine Clinique et Experimentale 10(5): 372-376
Miyazaki, J. 2018: IIi .Current Status of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 33-37
Held, J.; Volpe, H. 1991: Bladder preserving combined modality therapy for invasive bladder cancer Oncology Nursing Forum 18(1): 49-57
Ericson, K.J.; Murthy, P.B.; Bryk, D.J.; Ramkumar, R.R.; Broughman, J.R.; Khanna, A.; Mian, O.Y.; Campbell, S.C. 2019: Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer Clinical Advances in Hematology and Oncology: H&o 17(12): 697-707
Burton, C.; Ma, Y. 2019: Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges Current Medicinal Chemistry 26(1): 5-28
Nikolic, A.; Vlajnic, M.; Ristanovic, M.; Petrovic, J.; Dimitrijevic, I.; Krivokapic, Z.; Radojkovic, D. 2017: Cell-free DNA as biomarker and source for mutation detection in primary colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 22(1): 178-183
Sekita, N.; Egoshi, K.; Hamano, S.; Matsuzaki, O. 2006: Ileovesical fistula caused by bladder cancer with bladder stone Hinyokika Kiyo. Acta Urologica Japonica 52(10): 793-796